1760 — Panion & BF Biotech Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual income statement for Panion & BF Biotech, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,574	1,569	1,901	2,399	1,882
Cost of Revenue
Gross Profit	864	814	912	1,319	974
Selling / General / Administrative Expenses
Research And Development
Other Operating Expenses
Total Operating Expenses	1,350	1,464	1,736	1,985	1,725
Operating Profit	224	105	165	414	157
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	226	89.4	183	333	169
Provision for Income Taxes
Net Income After Taxes	161	27.9	104	182	77.2
Minority Interest
Net Income Before Extraordinary Items
Net Income	161	27.9	104	182	77.2
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	161	27.9	104	182	77.2
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.14	0.356	1.32	2.08	0.902
Dividends per Share